ClinicalTrials.gg
RecruitingNCT07614464CAPFISOBEANZUpdated Nov 6, 2026

Effects of Obesity on Physical Abilities and Daily Living Activities in Elderly Adults

An observational study in Obesity and Sarcopenic Obesity, sponsored by Istituto Auxologico Italiano. Recruiting at 1 site in Italy. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Istituto Auxologico Italiano · Observational

How we know

From the registry’s dates

  • Started May 2025; still recruiting 1 year 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
160
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 42 studies in Obesity by Istituto Auxologico Italiano — 11 open to participants now, 12 under way, none of them phase 3. Obesity · Istituto Auxologico Italiano.

Planned enrollment
6th of 20
160 · median 80
Started
2025
the only one that year
Observational
20 of 42
5 open now
Primary completion
2026-12
later than 7 of 11 live
Registered
41st of 42
by date

Among the 42 studies in Obesity by Istituto Auxologico Italiano, this one is the 6th largest by planned enrollment of the 20 observational ones that give a count, is the only one that started in 2025, is one of 20 observational ones, reaches primary completion later than 7 of the 11 other live ones, and was the 41st registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

11 of the 42 studies in Obesity by Istituto Auxologico Italiano are open now, in 1 country. Recruiting first, the newest first:

5 more — sign in →

By country, each count listing its studies:

All 11 open studies →

Where they have run

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 65 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 42 studies in Obesity by Istituto Auxologico Italiano, or all of them as a file.
02

Study summary

Obesity is a significant health problem whose prevalence has tripled worldwide in the last fifty years, also involving older people. Older people present sarcopenia, characterized by the progressive loss of muscle mass and strength. Sarcopenia, accompanied by an increase in adipose tissue, causes a specific condition called sarcopenic obesity. The increase in adipose tissue and the decrease in muscle mass determines a reduction in strength and physical abilities necessary to perform everyday activities of daily living in obese older people.

To understand how the condition of excess adipose tissue influences the activities of daily living of older people with obesity, it is necessary to compare the physical abilities, body composition, and results of various motor skills with normal-weight subjects, corrected for sex and age.

03

Conditions studied

  • Obesity
  • Sarcopenic Obesity

Browse trials for

Keywords

  • Ageing
  • Obesity
  • Physical performance
  • Visceral adiposity
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Hospitalized obese elderly following a 3-week integrated metabolic rehabilitation program

+ Normal weight elderly attending correct lifestyle program in their home town

Eligibility criteria

Obese elderly:

Inclusion Criteria:

  • Both sexes
  • > 35 kg/m2
  • Age > 65 years
  • Hospitalized for a 3-week integrated metabolic rehabilitation program

Exclusion Criteria:

  • Absence of signed

Normal weight elderly:

Inclusion Criteria:

  • Both sexes
  • Body Mass Index 20-25 kg/m2
  • Age > 65 years
  • Attendance of healthy lifestyle program in their home town

Exclusion Criteria:

  • Absence of signed informed consent
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
160 participants (estimated)
Patient registry
No

Groups and cohorts

  • Obese elderly

    Obese men and women of 65 years and older

    Other: Fitness tests and questionnaires

  • Normal weight elderly

    Normal weight men and women of 65 years and older

    Other: Fitness tests and questionnaires

Interventions

  • OtherFitness tests and questionnaires

    Anthropometric measurements, physical fitness tests and daily life questionnaires

06

What researchers measure

Primary outcomes

  1. Fat mass

    Fat mass as assessed by bioelectrical impedance

    Time frame: Baseline

  2. Lean mass

    Lean mass as assessed by bioelectrical impedance

    Time frame: Baseline

  3. Barthel Index

    Level of independence in 10 basic daily activities (ADLs) Total score ranges from 0 to 100

    Time frame: Baseline

  4. Handgrip test

    Score in kilograms (kg) using a hand dynamometer

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
  • Istituto Auxologico Italiano IRCCS, Site Piancavallo
    Oggebbio, 28824, Italy
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for Dec 2026, 19 months after the start.

Of 796 non-industry observational studies under Obesity, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 106. This study's planned 19 months is below that.

Counting every sponsor, half of 842 studies reached it within 39 months; a quarter within 17 and three quarters within 96.

How these figures are worked out, and which studies are left out of them.

Registered
May 22, 2026
First posted
May 29, 2026
StartActual
May 29, 2025
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date
1 update, last Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    Minor edits only
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07614464
Responsible party
Sponsor
First posted
May 29, 2026
Start date
May 29, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Nov 6, 2026

Study contacts

Alessandro Sartorio, MD
Contact
sartorio@auxologico.it
+3902619111 ext. 2426
Luca Grappiolo, Dr
Contact
luca.grappiolo@auxologico.it
+3902619111 ext. 2894

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion